I do have concerns about igf 1 as a competitor, but i do not really understand the science.
The fact so many experts in autism have joined such as Joe Horrigan suggests to me there is a difference and probably a meaningful one as the numerous peolpe who have joined the company do understand the science.
Would these experts have joined if igf 1 was going to win the race? It would have been obvious to them if the answer was yes.
- Forums
- ASX - By Stock
- Wider autism efficacy potential for nnz-2566
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.16%
!
$14.18

I do have concerns about igf 1 as a competitor, but i do not...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.18 |
Change
0.300(2.16%) |
Mkt cap ! $1.765B |
Open | High | Low | Value | Volume |
$13.91 | $14.20 | $13.81 | $5.779M | 411.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2953 | $14.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.19 | 2748 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2953 | 14.100 |
2 | 1390 | 14.080 |
1 | 1524 | 14.060 |
1 | 2265 | 13.950 |
1 | 11477 | 13.940 |
Price($) | Vol. | No. |
---|---|---|
14.190 | 2748 | 2 |
14.200 | 2653 | 4 |
14.230 | 3278 | 1 |
14.250 | 1816 | 2 |
14.320 | 1000 | 1 |
Last trade - 16.10pm 09/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |